0.50Open0.50Pre Close0 Volume37 Open Interest17.50Strike Price0.00Turnover30.16%IV3.03%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier20DDays to Expiry0.50Extrinsic Value100Contract SizeAmericanOptions Type0.5180Delta0.3217Gamma34.94Leverage Ratio-0.0134Theta0.0047Rho18.10Eff Leverage0.0164Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet